Xeltis expands Medical Advisory Board with World Leading Experts in Clinical Nephrology
- Leading nephrologists Dr. An De Vriese and Dr. Monnie Wasse join as Company continues clinical advancement
EINDHOVEN, The Netherlands, 11 March 2025 – Xeltis, a leading developer of transformative implants that enable the natural creation of living and long-lasting vessels, today announces the appointment of clinical nephrology experts An De Vriese, MD, PhD and Haimanot (Monnie) Wasse, MD, MPH to its Medical Advisory Board (MAB).
